Day One
11.41
+0.93
+8.87%
DAWN
02-06 16:00:00(美东时间)
高
11.50
开
11.06
量
312.98万股
总市值
11.72亿
低
10.84
换
3.05%
额
3540.69万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
JZee
01-13 16:23
一年多前给
$Day One(DAWN)$
把脉的时候,算账算保守了。现在已经卖到1.5亿,预计今年2.3亿。虽然有积累的病人,这样的放量速度也预示了峰值销量应该不止我之前的两三亿的保守估计。其次,这个疗法正在尝试上一线,那样使用时间会更长,销量会大增。再次,最近收购的
$Mersana Therapeutics(MRSN)$
...
@JZee :
Day One,脑瘤儿童新希望
$Day One(DAWN)$
Day One Biopharmaceuticals是一家处于临床阶段的生物制药公司,在开发儿童低级别胶质瘤(pLGG)的创新靶向治疗方面取得了重大进展。他们的主要药物候选物tovorafenib(DAY101)旨在满足这一常见儿童脑肿瘤患儿和青少年对有效且耐受性良好的治疗的迫切需求。
此药的批准决定日...
2讨论
·
10赞
股事小兵
01-12 20:20
$Day One(DAWN)$
首日公布2025年OJEMDA™净产品收入初步数据,并提供2026年净产品收入指导 2025年初净产品收入为1.554亿美元,同比增长172%;OJEMDA 2026年美国净产品收入预计为2.25亿至2.5亿美元
1讨论
·
3赞
OYang
2025-11-13 19:10
#药闻简讯#
$Day One(DAWN)$
每股 25 美元现金,另加根据或有价值权协议(CVR)可能支付的每股最高 30.25 美元现金收购
$Mersana Therapeutics(MRSN)$
Day One 将通过要约收购和后续合并的方式收购 Mersana, 收购价格为每股 25.00 美元现金,另加最高可达每股 30.25 美元的或有价值权,交易总价...
1转发
·
12赞
Day One(DAWN)
2025-11-18 05:15
$Day One(DAWN)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-008933 Act: 33 Size: 5 KB
网页链接
Day One(DAWN)
2025-11-13 20:05
$Day One(DAWN)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-110833 Size: 47 KB
网页链接
Day One(DAWN)
2025-11-15 05:15
$Day One(DAWN)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-112478 Size: 94 KB
网页链接
Day One(DAWN)
2025-11-19 08:05
$Day One(DAWN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001855298-25-000007 Size: 17 KB
网页链接
Day One(DAWN)
2025-12-29 21:35
$Day One(DAWN)$
SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-25-124535 Size: 37 KB
网页链接
Day One(DAWN)
01-06 22:35
$Day One(DAWN)$
8-K Current report, items 1.01, 2.01, 7.01, and 9.01 Accession Number: 0001104659-26-001127 Act: 34 Size: 8 MB
网页链接
chuminhua
2025-11-14 20:14
11月13日,Day One Biopharmaceuticals
$Day One(DAWN)$
宣布与Mersana Therapeutics
$Mersana Therapeutics(MRSN)$
签署最终并购协议。Day One将以每股25美元现金收购Mersana所有流通股,前期款总价值约1.29亿美元(基于Mersana约5180万股计算),并提供潜在的或有价值权(CVR)。若Mersana的ADC项...
Day One(DAWN)
2025-11-19 08:05
$Day One(DAWN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001863107-25-000005 Size: 24 KB
网页链接
Day One(DAWN)
2025-11-18 05:15
$Day One(DAWN)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-008930 Act: 33 Size: 5 KB
网页链接
Day One(DAWN)
2025-11-18 05:15
$Day One(DAWN)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-008931 Act: 33 Size: 5 KB
网页链接
Day One(DAWN)
2025-11-18 05:15
$Day One(DAWN)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-008926 Act: 33 Size: 5 KB
网页链接
Day One(DAWN)
01-31 06:25
$Day One(DAWN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001744507-26-000002 Size: 8 KB
网页链接
Day One(DAWN)
昨天02:25
$Day One(DAWN)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-26-000409 Act: 34 Size: 11 KB
网页链接
Day One(DAWN)
2025-11-25 00:25
$Day One(DAWN)$
8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-292096 Act: 34 Size: 18 MB
网页链接
Day One(DAWN)
2025-11-27 05:15
$Day One(DAWN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001863107-25-000007 Size: 16 KB
网页链接
Day One(DAWN)
2025-12-06 05:05
$Day One(DAWN)$
SC TO-T Tender offer statement by Third Party Accession Number: 0001104659-25-118858 Size: 2 MB
网页链接
Day One(DAWN)
2025-11-13 19:55
$Day One(DAWN)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-110815 Size: 9 MB
网页链接